The biotech drug developer posted revenue of $29 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks ...
News
- FibroGen: 3Q Earnings Snapshot
- Coherus BioSciences: 3Q Earnings Snapshot
Coherus BioSciences shares have climbed 36 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $11.93, ...
- Spectrum Pharma: 3Q Earnings Snapshot
The biotechnology company posted revenue of $25.3 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected ...
- Local cannabis company raises $20M for expansion
San Antonio-based medical cannabis company Alternate Health Corp. ... to solve global challenges in energy, aerospace, the Internet and biotech.
- Delaware pharma company wins lawsuit over secrets, no money
The News Journal reports a jury ruled Wednesday that Flexus Biosciences had "misappropriated" an Incyte Corp. trade secret, but that Flexus hadn't ...